Saturday, 11 October 2025
08.15 – 09.00 Registrations
09.00 – 09.15 Introduction: A.G. Tzioufas - E. Andreakos
Chairs: A. Goules - L. Chatzis
Current therapeutic considerations and future perspectives in the treatment of scleroderma
Τ. Dimitroulas
Recent advances in the pathogenesis of scleroderma
D. Daoussis
10.15 – 11.00 Plenary lecture
Chairs: D. Vassilopoulos - A. G. Tzioufas
Relapse prediction in ANCA associated vasculitis
M. Little
11.00 – 11.15 Coffee break
11.15 – 12.00 Sjogren’s Disease
Chair: R. Giakomelli - M. Bombardieri
New Insights in the Pathogenesis of Sjogren’s Disease
A. Goules
Learning from clinical studies in Sjogren’s Disease
L. Chatzis
12.00 – 12.45 Plenary Lecture
Chairs: C. Mauri - I. Alevizos
The pathophysiology of ectopic lymphoid structures in autoimmune diseases
M. Bombardieri
12.45 – 13.15 Myositis
Chairs: D. Daousis - G. Fragoulis
Current pathogenetic aspects in myositis
C. Mavragani
13.15 – 14.30 Break
14.30 – 15.45 Co-morbidities in autoimmune diseases
Chairs: S. Gazi - A. Georgountzos
Advances in Pathogenesis and treatment of Psoriatic Arthritis
G. Katsifis
Atherosclerosis in SLE and antiphospholipid syndrome. Current status and future perspectives
M. Tektonidou
Comorbidities in patients with systemic vasculitides
C. Koutsianas
15.45 – 16.45 Neutrophils in autoinflammatory Diseases
Chairs: S-N. Liossis - G. Fragoulis
Differences and similarities in clinical cellular and molecular level between autoimmune and autoinflammatory diseases
P. Skendros
Neutrophils in the pathobiology of chronic inflammation
K. Kambas
16.45 – 17.30 Plenary lecture
Chairs: A. G. Tzioufas - A. Goules
The role of endothelial cells in systemic autoimmune diseases. Pathogenetic and therapeutic considerations
R. Giacomelli
17.30 - 17.45 Coffee break
17.45 – 18.45 Seronegative spondyloarthropathies
Chairs: P. Trontzas - S. Sougioultzis
Current advances in treatment of patients with Seronegative spondyloarthropathies
G. Fragoulis
Pathogenetic aspects of Th17 related diseases
G. Katsifis
18.45 - 19.45 Systemic Lupus Erythematosus
Chairs: S-N. Liossis - M. Tektonidou
What's new in the pathogenesis of SLE
G. Bertsias
New and emerging therapies for SLE
S-N. Liossis
19.45 – 20.15 Plenary Lectures
Chairs: A. G. Tzioufas - V. Soumelis
Cryoglobulinemia, one name two diseases
P. Cacoub
Sunday, 12 October 2025
Session: Basic and translational immunology
09.00 – 10.45 Work in progress (12min talks)
Chairs: E. Andreakos - V. Soumelis – A. Goules – M. Bombardieri
Basic and Translational
The expression map of IFN-λR1 in mice
A. Piperakis
Lipid mediators in health and disease
M. Papadaki
Steroid effects on cell sub populations and small lipid mediators in patients with Giant Cell Arteritis
D. Palamidas
Inflamatory extra cellular traps in sequential biopsies of patients with giant cell arteritis following treatment with IL6R inhibition
Spyropoulos
Clinical
P. Panagopoulos
Κ. Panagiotopoulos
A. Koutsogianni
10.45 – 11.00 Coffee break
11.00 – 13.00 Mechanisms of Inflammation and Autoimmunity
Chairs: E. Andreakos – C. Mauri
ΤΒΑ
V. Soumelis
Regulatory B cells in immunity and autoimmunity
C. Mauri
Type III IFNs in obesity and cardiovascular disease
M. Salagianni
The role of tumour microenvironment in the pathogenesis of paraneoplastic neurological syndromes
Ch. Alexopoulos
13.00 - 13.45 Βreak
13.45 –14.45 Interferons, immunity and disease
Chairs: C. Alexopoulos – I. Galani
Ι. Galani
Th. Alissafi
14.45 – 15.15 New era of treatments. Current perspectives and future developments
Chairs: A. G. Tzioufas – A. Goules
I. Alevizos
15.15 - 15.30 Wrap-up
A. G. Tzioufas – E. Andreakos
